cancer

Nanotech, immunotherapy combo vaccinates mouse against cancer
Nanotech, immunotherapy combo vaccinates mouse against cancer
Drug Delivery Business News
nanotech
immunotherapy
vaccines
cancer
Flag link:
New study of FDA cites the flaws behind rapid-fire cancer drug OKs
New study of FDA cites the flaws behind rapid-fire cancer drug OKs
Endpoints
FDA
drug approvals
cancer
oncology
Flag link:
A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
NY Times, NY
cancer
oncology
clinical trials
patients
Flag link:
Ending the era of $100,000 cancer drugs
Ending the era of $100,000 cancer drugs
Pharmafile
cancer
drug pricing
oncology
Flag link:
Making the Promise of Immunotherapeutics into Reality
Making the Promise of Immunotherapeutics into Reality
Elsevier
immunotherapy
cancer
Flag link:
GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research
GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research
Endpoints
GSK
reorganization
Emma Walmsley
Pharma CEOs
R&D
cancer
Flag link:
The Startling History Behind Merck's New Cancer Blockbuster
The Startling History Behind Merck's New Cancer Blockbuster
Forbes
Merck
Keytruda
cancer
R&D
Organon
Flag link:
King cancer: The top 10 therapeutic areas in biopharma R&D
King cancer: The top 10 therapeutic areas in biopharma R&D
Endpoints
R&D
cancer
neurology
infection
immunology
cardiovascular disease
diabetes
Flag link:
The Fastest Growing Cancer Company You've Never Heard Of
The Fastest Growing Cancer Company You've Never Heard Of
Motley Fool
devices
Novocure
tumor treating fields
cancer
TTFields
glioblastoma
ovarian cancer
pancreatic cancer
lung cancer
Flag link:
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
Motley Fool
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
AbbVie
JNJ
Imbruvica
Pfizer
Ibrance
cancer
Flag link:
How Reproducible are Preclinical Study Results?
How Reproducible are Preclinical Study Results?
Xtalks
preclinical study results
cancer
oncology
clinical trials
Flag link:
Marketing cancer drugs is costly, but pharma has room for savings: report
Marketing cancer drugs is costly, but pharma has room for savings: report
Fierce Pharma
pharma marketing
cancer
Flag link:
Personalized cancer vaccines vanquish melanoma in small but encouraging study
Personalized cancer vaccines vanquish melanoma in small but encouraging study
Stat
personalized medicine
cancer
vaccines
melanoma
Keytruda
Merck
Neon Therapeutics
Flag link:
Two cancer drug prices have already been hiked by 8% this year
Two cancer drug prices have already been hiked by 8% this year
Marketwatch
drug pricing
cancer
Amgen
Blincyto
Teva Pharmaceutical
Treanda
lymphoma
leukemia
Flag link:
Vivace Therapeutics Comes Out of Stealth With $25M for Cancer Drugs
Vivace Therapeutics Comes Out of Stealth With $25M for Cancer Drugs
Xconomy
Vivace Therapeutics
cancer
Flag link:
Standing out in crowded cancer market
Standing out in crowded cancer market
Medical Marketing and Media
cancer
Opdivo
Bristol-Myers Squibb
Flag link:
FDA to Clear Path for Drugs Aimed at Cancer-Causing Genes
FDA to Clear Path for Drugs Aimed at Cancer-Causing Genes
Bloomberg
FDA
gene therapy
tumor-agnostic therapies
cancer
Scott Gottlieb
Flag link:
Cancer's Big Infrastructure Problem
Cancer's Big Infrastructure Problem
Forbes
cancer
oncology
personalized medicine
clinical trials
clinical trial data
Flag link:
Novartis’s Next Challenge: Pricing Breakthrough Cancer Treatment
Novartis’s Next Challenge: Pricing Breakthrough Cancer Treatment
Bloomberg
Novartis
drug pricing
CTL019
cancer
CAR-T
Flag link:
[video]Bristol-Myers Squibb CEO: Critical that treatments reach patients
[video]Bristol-Myers Squibb CEO: Critical that treatments reach patients
Yahoo/CNBC
patients
cancer
Bristol-Myers Squibb
drug pricing
ASCO 2017
Giovanni Caforio
Flag link: